Catawba Capital Management Trimmed Mastercard Cl A (MA) Stake; Edwards Lifesciences (EW) Covered By 22 Bullish Analysts Last Week

Edwards Lifesciences Corporation (NYSE:EW) Logo

Among 29 analysts covering Edwards Lifesciences Corp (NYSE:EW), 22 have Buy rating, 1 Sell and 6 Hold. Therefore 76% are positive. Edwards Lifesciences Corp had 113 analyst reports since July 30, 2015 according to SRatingsIntel. The stock of Edwards Lifesciences Corporation (NYSE:EW) earned “Hold” rating by Zacks on Tuesday, September 22. The stock of Edwards Lifesciences Corporation (NYSE:EW) has “Outperform” rating given on Monday, August 10 by Credit Suisse. The firm earned “Neutral” rating on Thursday, February 2 by BTIG Research. The stock of Edwards Lifesciences Corporation (NYSE:EW) has “Buy” rating given on Thursday, January 21 by Suntrust Robinson. The firm earned “Buy” rating on Tuesday, March 20 by Cowen & Co. The rating was maintained by Canaccord Genuity on Sunday, October 8 with “Buy”. On Thursday, February 1 the stock rating was maintained by Cowen & Co with “Buy”. Jefferies maintained it with “Buy” rating and $132.0 target in Tuesday, September 5 report. The rating was maintained by Canaccord Genuity on Thursday, February 1 with “Buy”. Barclays Capital maintained it with “Equal-Weight” rating and $105 target in Thursday, April 7 report. See Edwards Lifesciences Corporation (NYSE:EW) latest ratings:

31/05/2018 Broker: Raymond James Rating: Outperform New Target: $152 Initiates Coverage On
25/04/2018 Broker: Canaccord Genuity Rating: Buy New Target: $174.0000 Maintain
25/04/2018 Broker: Northland Capital Rating: Hold Downgrade
24/04/2018 Broker: BTIG Research Rating: Hold
10/04/2018 Broker: SunTrust Rating: Buy New Target: $180.0000 Maintain
22/03/2018 Broker: Canaccord Genuity Rating: Buy New Target: $174.0 Maintain
20/03/2018 Broker: Cowen & Co Rating: Buy New Target: $165.0 Maintain
15/02/2018 Broker: Canaccord Genuity Rating: Buy New Target: $174.0 Maintain
02/02/2018 Broker: Guggenheim Rating: Buy New Target: $162.0 Maintain
01/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $155.0 Maintain

Catawba Capital Management decreased Mastercard Inc Cl A (MA) stake by 8.18% reported in 2018Q1 SEC filing. Catawba Capital Management sold 3,462 shares as Mastercard Inc Cl A (MA)’s stock rose 7.48%. The Catawba Capital Management holds 38,857 shares with $6.81 million value, down from 42,319 last quarter. Mastercard Inc Cl A now has $208.84B valuation. The stock increased 0.25% or $0.5 during the last trading session, reaching $200.04. About 2.30 million shares traded. Mastercard Incorporated (NYSE:MA) has risen 56.80% since June 11, 2017 and is uptrending. It has outperformed by 44.23% the S&P500. Some Historical MA News: ; 07/03/2018 – MASTERCARD TO INTEGRATE ITS PHYSICAL & DIGITAL PAYMENTS TEAMS; 26/04/2018 – Mastercard’s Predictive Analytics Solution Minimizes Risk for Retailers; 02/05/2018 – Mastercard 1Q Gross Dollar Volume 14%; 06/03/2018 – Vipera Launches Mobile Payment System in Collaboration With Mastercard; 02/05/2018 – MASTERCARD 1Q NET REV. $3.58B, EST. $3.25B; 03/05/2018 – A drop in customers buying cryptocurrencies with credit cards slightly dampened Mastercard’s quarterly growth, according to its earnings call; 07/03/2018 – MASTERCARD INC – ANNOUNCED INTEGRATION OF ITS PHYSICAL AND DIGITAL PAYMENTS TEAMS UNDER ONE ORGANIZATION, EFFECTIVE APRIL 2, 2018; 17/04/2018 – Mastercard Closes Above 50-Day Moving Average: Technicals; 05/04/2018 – Mastercard Names Ann Cairns Vice Chairman; 29/05/2018 – Mastercard Presenting at AllianceBernstein Conference Tomorrow

Among 40 analysts covering Mastercard Incorporated (NYSE:MA), 35 have Buy rating, 0 Sell and 5 Hold. Therefore 88% are positive. Mastercard Incorporated has $212.0 highest and $29 lowest target. $169.25’s average target is -15.39% below currents $200.04 stock price. Mastercard Incorporated had 131 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cantor Fitzgerald on Thursday, September 28. Jefferies maintained the stock with “Buy” rating in Tuesday, August 25 report. Piper Jaffray maintained the stock with “Overweight” rating in Thursday, December 31 report. Wells Fargo maintained Mastercard Incorporated (NYSE:MA) on Thursday, March 29 with “Buy” rating. KeyBanc Capital Markets maintained Mastercard Incorporated (NYSE:MA) rating on Wednesday, October 18. KeyBanc Capital Markets has “Buy” rating and $165.0 target. Keefe Bruyette & Woods maintained the shares of MA in report on Thursday, February 1 with “Buy” rating. Tigress Financial maintained the stock with “Buy” rating in Thursday, February 8 report. The stock of Mastercard Incorporated (NYSE:MA) has “Buy” rating given on Monday, October 16 by Robert W. Baird. Citigroup maintained the stock with “Buy” rating in Wednesday, October 18 report. On Thursday, July 27 the stock rating was maintained by Piper Jaffray with “Buy”.

Since January 2, 2018, it had 0 buys, and 8 selling transactions for $59.23 million activity. Haythornthwaite Richard also sold $866,104 worth of Mastercard Incorporated (NYSE:MA) shares. Fraccaro Michael had sold 4,122 shares worth $741,960. $1.09 million worth of Mastercard Incorporated (NYSE:MA) was sold by CARLUCCI DAVID R. Another trade for 17,496 shares valued at $3.25M was made by Vosburg Craig on Thursday, May 3. McLaughlin Edward Grunde had sold 17,167 shares worth $2.61 million on Tuesday, January 2. Shares for $5.53 million were sold by Murphy Timothy H on Monday, March 19. BANGA AJAY sold $44.45 million worth of stock.

Analysts await Mastercard Incorporated (NYSE:MA) to report earnings on July, 26. They expect $1.54 earnings per share, up 40.00% or $0.44 from last year’s $1.1 per share. MA’s profit will be $1.61 billion for 32.47 P/E if the $1.54 EPS becomes a reality. After $1.50 actual earnings per share reported by Mastercard Incorporated for the previous quarter, Wall Street now forecasts 2.67% EPS growth.

More notable recent Mastercard Incorporated (NYSE:MA) news were published by: Seekingalpha.com which released: “Why I Would Still Choose Mastercard Over Visa” on May 28, 2018, also Seekingalpha.com with their article: “Mastercard: Is It Overvalued?” published on May 16, 2018, Seekingalpha.com published: “Mastercard – Priceless” on May 29, 2018. More interesting news about Mastercard Incorporated (NYSE:MA) were released by: Seekingalpha.com and their article: “Are You Swimming Naked?” published on June 06, 2018 as well as Fool.com‘s news article titled: “Is Visa Inc. a Buy?” with publication date: June 07, 2018.

Investors sentiment decreased to 0.86 in 2018 Q1. Its down 0.05, from 0.91 in 2017Q4. It is negative, as 47 investors sold MA shares while 533 reduced holdings. 121 funds opened positions while 378 raised stakes. 750.68 million shares or 1.84% less from 764.78 million shares in 2017Q4 were reported. Martin Limited Liability Corporation accumulated 145,877 shares or 6.48% of the stock. Prentiss Smith And Incorporated invested in 0.26% or 2,877 shares. Moreover, Fmr Ltd Company has 0.77% invested in Mastercard Incorporated (NYSE:MA). Sather Fincl Grp reported 2.51% of its portfolio in Mastercard Incorporated (NYSE:MA). Boulegeris Invests invested in 20,077 shares or 1.93% of the stock. 2,055 are held by Cornerstone Advisors. Arrow Fincl has 0.12% invested in Mastercard Incorporated (NYSE:MA) for 2,971 shares. Ami Asset Management Corp reported 242,886 shares. 13,962 are held by Hl Limited Liability Com. Factory Mutual Ins Co holds 374,800 shares. 210,887 were reported by Teachers Retirement Of The State Of Kentucky. First Pacific Ltd Liability Corporation accumulated 5,700 shares. Baldwin Brothers Inc Ma, Massachusetts-based fund reported 2,786 shares. Manchester Cap Limited Liability Corp accumulated 1,770 shares or 0.05% of the stock. 183,950 were accumulated by Metropolitan Life Insurance.

More news for Edwards Lifesciences Corporation (NYSE:EW) were recently published by: Seekingalpha.com, which released: “Don’t Let Go Of Hasbro – Cramer’s Lightning Round (6/5/18)” on June 06, 2018. Ocbj.com‘s article titled: “Midday Stock Roundup” and published on May 31, 2018 is yet another important article.

The stock increased 0.57% or $0.81 during the last trading session, reaching $142.82. About 1.01M shares traded. Edwards Lifesciences Corporation (NYSE:EW) has risen 19.08% since June 11, 2017 and is uptrending. It has outperformed by 6.51% the S&P500. Some Historical EW News: ; 24/04/2018 – EDWARDS LIFESCIENCES 1Q ADJ. EPS $1.22, EST. $1.11; 24/04/2018 – EDWARDS LIFESCIENCES – 2018 ADJ SHR OUTLOOK RAISED TO $4.50 TO $4.70 FROM $4.43 TO $4.63; 24/04/2018 – Edwards Lifesciences 1Q EPS 96c; 25/04/2018 – EDWARDS LIFESCIENCES CORP EW.N : NORTHLAND CAPITAL CUTS TO MARKET PERFORM RATING; 26/04/2018 – V-WAVE LTD – CO’S EXISTING INVESTORS, JOHNSON & JOHNSON INNOVATION (JJDC INC.) ,EDWARDS LIFESCIENCES ALSO PARTICIPATED IN FUNDING ROUND; 24/04/2018 – Edwards Lifesciences Sees FY Sales $3.5B-$3.9B; 22/05/2018 – Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards SAPIEN 3 Valve; 22/05/2018 – EDWARDS LIFESCIENCES – EDWARDS SAPIEN 3 VALVE DATA DEMONSTRATED CONSISTENCY WITH THOSE RESULTS ACHIEVED IN EARLIER CONTROLLED CLINICAL TRIALS; 24/04/2018 – EDWARDS LIFESCIENCES – REMAINS CONFIDENT IN ACHIEVING HIGHER END OF 2018 SALES OUTLOOK RANGE OF $3.5 BLN TO $3.9 BLN; 24/04/2018 – EDWARDS LIFESCIENCES – QTRLY SHR $0.96; QTRLY ADJ SHR $1.22; QTRLY SALES $894.8 MLN, UP 1.3 PCT

Mastercard Incorporated (NYSE:MA) Institutional Positions Chart